Cubist Systematic Strategies, LLC Autolus Therapeutics PLC Transaction History

Cubist Systematic Strategies, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$5.39 - $7.29 $171,450 - $231,887	-31,809 Reduced 99.5%	160 $1,000
Q4 2023 Feb 14, 2024	BUY	$2.13 - $6.63 $68,093 - $211,954	31,969 New	31,969 $205,000
Q1 2023 May 15, 2023	BUY	$1.75 - $2.25 $212,402 - $273,089	121,373 Added 971.99%	133,860 $246,000
Q4 2022 Feb 14, 2023	SELL	$1.74 - $3.27 $227 - $428	-131 Reduced 1.04%	12,487 $23,000
Q3 2022 Nov 14, 2022	SELL	$2.04 - $3.76 $18,092 - $33,347	-8,869 Reduced 41.28%	12,618 $27,000
Q2 2022 Aug 15, 2022	BUY	$2.04 - $4.68 $43,833 - $100,559	21,487 New	21,487 $61,000
Q1 2022 May 16, 2022	SELL	$3.52 - $5.46 $94,526 - $146,622	-26,854 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.1 - $7.0 $136,955 - $187,978	26,854 New	26,854 $139,000
Q3 2021 Nov 15, 2021	SELL	$5.32 - $7.37 $107,698 - $149,198	-20,244 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.78 - $7.96 $27,389 - $45,610	-5,730 Reduced 22.06%	20,244 $134,000
Q1 2021 May 17, 2021	BUY	$5.49 - $9.36 $142,597 - $243,116	25,974 New	25,974 $149,000
Q2 2020 Aug 14, 2020	SELL	$5.38 - $16.14 $1,318 - $3,954	-245 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.2 - $13.0 $672 - $2,080	160 Added 188.24%	245 $1,000
Q4 2019 Feb 14, 2020	BUY	$11.13 - $16.28 $946 - $1,383	85 New	85 $1,000

104

163M

2.8K

13.4K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $208M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.